Philadelphia, USA – August 15th, 2016. Leading pharmaceutical outsourcing services provider PCI Pharma Services has announced the appointment of Jim Neville as Operations Director at its Tredegar, UK site, to lead the continuing growth of its manufacturing business.
As part of the established Operations Team, Jim joins PCI Pharma Services with responsibility for all of the manufacturing and engineering activities at the Tredegar, UK site. With over 30 years of experience in the pharmaceutical industry, he has held several senior roles in other major pharmaceutical companies, most recently as Site Leader at Pfizer’s biotech organization and previously at Wyeth Europa on AVP Technical Operations with the responsibility for New Product Introduction, Technical Operations, Contract Manufacturing and Artwork and Labelling.
Commenting on his appointment, Norman Barras, Managing Director of the Tredegar, UK site, said: “We are delighted to welcome Jim Neville to the PCI Pharma Services team. He brings with him robust experience that will be a key asset to our teams and clients during an exciting time of expansion, as we look to demonstrate continued investment at the Tredegar facility. We are looking forward to working with Jim as the site continues to evolve and grow.”
Jim said: “I’m excited to be part of the team at PCI’s Tredegar site and apply my previous experience to the role. I have a long history of working in pharmaceutical manufacturing and packaging, and plan to leverage my experience to support our clients as they look to more effectively develop and commercialize new medicines. I am particularly excited about the new Tredegar site expansion and what that offers our clients.”
In July 2015 PCI announced a facilities expansion of its award winning manufacturing center of excellence in Tredegar, UK.  The announcement follows other recent capital investments expanding the capabilities and manufacturing capacity of the specialized site.
To find out more about PCI, please visit www.pciservices.com.